Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
03/2005
03/24/2005US20050065171 Therapy, prevention leukemia; antitumor agents
03/24/2005US20050065168 Dissolving in solvent; precipitation; isolation; sleep disorders; antiepileptic agents; muscle relaxants
03/24/2005US20050065115 N,N-dihalogenated amino acids and derivatives
03/24/2005US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents
03/24/2005US20050064548 Yeast ectopically expressing abnormally processed proteins and uses therefor
03/24/2005US20050064034 Oral extended-release composition
03/24/2005US20050063938 Tertiary amine functional complex polyester polymers and methods of production and use
03/24/2005US20050063911 Accurate metered single inhalation administration
03/24/2005US20050063903 Combined use of cruciferous indoles and chelators for the treatment of papilloma virus-related conditions
03/24/2005CA2578375A1 Vaccine immunotherapy for immune suppressed patients
03/24/2005CA2542303A1 A composition and method of treatment for urogenital conditions
03/24/2005CA2538843A1 Animal model for protease activity and liver damage
03/24/2005CA2538754A1 Inhibition of inward sodium currents in cancer
03/24/2005CA2538395A1 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
03/24/2005CA2538245A1 Oligonucleotides targeting prion diseases
03/24/2005CA2538237A1 Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
03/24/2005CA2538231A1 A method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration
03/24/2005CA2538076A1 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates
03/24/2005CA2537782A1 Water-soluble polyaminoamides as sunscreen agents
03/24/2005CA2536746A1 Hydrophobic drug compositions containing reconstitution enhancer
03/24/2005CA2536735A1 Methods for determining cd8+ t-cell epitopes
03/24/2005CA2535279A1 Compounds that modulate neuronal growth and their uses
03/24/2005CA2531878A1 Therapeutic use of g53135-05(fgf-20) in radiation protection
03/23/2005EP1516617A2 Use of a thiazolidinedione for reducing apoptosis of pancreatic beta cells
03/23/2005EP1516184A2 Cell penetrating peptides
03/23/2005EP1515751A1 Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same
03/23/2005EP1152764A4 Compositions and methods for use in targeting vascular destruction
03/23/2005EP1027064B1 A process for the removal of undersired toxic alkaloids from plants or from vegetable preparations
03/23/2005CN1599726A Pyrimidine compounds
03/23/2005CN1599613A Combinations for the treatment of immunoinflammatory disorders
03/23/2005CN1599605A Pharmaceutical compositions and methods for administering EP2 receptor selective agonists
03/23/2005CN1599601A Plaster for the treatment of dysfunctions and disorders of nails
03/22/2005US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents
03/22/2005US6869625 Administering an effective amount of an Argyrolobium roseum extract containing flavonoid glycoside compound for therapy of hyperglycemia non-insulin dependent diabetes mellitus in an animal
03/22/2005US6869617 Dissolving the organic compound in the water-miscible first solvent to form a solution, mixing solution with second solvent to define a pre-suspension; adding energy to the pre-suspension to form particles
03/17/2005WO2005023208A1 Cosmetic composition comprising camel milk or components thereof
03/17/2005WO2005023205A2 Compositions and methods for yersinia pestis treatment
03/17/2005WO2005023204A2 Aromatic prodrugs of propofol, compositions and uses thereof
03/17/2005WO2005023203A2 Transition state analog inhibitors of ricin a-chain
03/17/2005WO2005023202A2 Tumor suppressor lkb1 kinase directly activates amp-activated kinase
03/17/2005WO2005023200A2 System and method for cooling internal tissue
03/17/2005WO2005023199A2 Socs-3 promoter methylation in cancer
03/17/2005WO2005023198A2 Modafinil compositions
03/17/2005WO2005023197A2 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas
03/17/2005WO2005023196A2 Compounds and methods
03/17/2005WO2005023195A2 Treatment of spinal cord injury
03/17/2005WO2005023193A2 Methods of treating endometriosis
03/17/2005WO2005023192A2 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/17/2005WO2005023191A2 Rage-related methods and compositions for treating glomerular injury
03/17/2005WO2005023189A2 Method of cox-2 selective inhibitor and nitric oxide-donating agent
03/17/2005WO2005023188A2 Compounds and methods
03/17/2005WO2005023187A2 Inhibitor of cardiac tachyarrhythmias
03/17/2005WO2005023186A2 Methods of identifying agents that inhibit the growth of cancer cells
03/17/2005WO2005023185A2 Pharmaceutical compositions and method of using levodopa and carbidopa
03/17/2005WO2005023184A2 Antibiotic product, use and formulation thereof
03/17/2005WO2005023183A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
03/17/2005WO2005023182A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/17/2005WO2005023181A2 Polymeric systems for controlled drug therapy
03/17/2005WO2005023180A2 Method for detecting cancer cells and monitoring cancer therapy
03/17/2005WO2005023179A2 Combination methods of treating cancer
03/17/2005WO2005023177A2 Human monoclonal antibodies against bacillusanthracis protective antigen
03/17/2005WO2005023176A2 Delivery of physiologixal agents with in-situ gels comprising anionic polysaccharides
03/17/2005WO2005023175A2 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
03/17/2005WO2005009330A3 Method of obtaining inhibitors of type ii dehydroquinase enzyme and precursors thereof
03/17/2005WO2005004808A3 TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS
03/17/2005WO2005000228A3 Synthesis of labeled oxalic acid derivatives
03/17/2005WO2005000214A3 Method for treating diseases using hsp90-inhibiting agents in combination with antibiotics
03/17/2005WO2004112690A3 2-aminobenzoyl derivatives
03/17/2005WO2004108084A3 Polymorphic forms of naltrexone
03/17/2005WO2004105692A3 Smooth muscle spasmolytic agents
03/17/2005WO2004103313A3 Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tpa) and tpa inhibitors useful therein
03/17/2005WO2004103305A3 Spiropyrazole compound
03/17/2005WO2004103297A3 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
03/17/2005WO2004100875A3 Benzimidazoles, compositions containing such compounds and methods of use
03/17/2005WO2004098501A3 Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
03/17/2005WO2004096120A3 Compounds that selectively bind to membranes of apoptotic cells
03/17/2005WO2004087061A3 Tubulin binding agents and corresponding prodrug constructs
03/17/2005WO2004084797A3 Type 2 diabetes mellitus-associated gene and utilization of the same
03/17/2005WO2004082633A3 A method of treating a systemic disease
03/17/2005WO2004082608A9 Ligands for tgf-beta binding proteins and uses thereof
03/17/2005WO2004075843A3 Glycosolated enkephalin agents
03/17/2005WO2004071399A3 Modulation of atp production or content in the hypothalamus
03/17/2005WO2004069165A3 Methods and compositions for the treatment of gastrointestinal disorders
03/17/2005WO2004066954A3 A therapeutic composition for the treatment of hiv-1 and hiv-2
03/17/2005WO2004066910A3 Controlled release modifying complex and pharmaceutical compositions thereof
03/17/2005WO2004060291A3 Uses of mammalian cytokine; related reagents
03/17/2005WO2002096865A8 Process for the preparation 3-aryl-2-hydroxypropionic acid derivative
03/17/2005US20050060766 Cloning non-human mammal through nuclear transfer/transplantation; tissue engineering and treatment of cancer, psoriasis, asthma and inflammation
03/17/2005US20050059921 Extracorporeal pathogen reduction system
03/17/2005US20050059727 Withanamide and withanolide compositions and method of use thereof
03/17/2005US20050059702 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine
03/17/2005US20050059655 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
03/17/2005US20050059645 Methods for the treatment of male and female sexual dysfunction
03/17/2005US20050059640 comprises valacyclovir hydrochloride, minocycline hydrochloride, and metronidazole
03/17/2005US20050059638 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
03/17/2005US20050059615 saturated complexes of steroids with cyclodextrins, used for enhancing mucous membrane bioavailability of sex hormones or antiinflammatory agents
03/17/2005US20050059613 Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium
03/17/2005US20050058699 Mixture of nonsteroidal, antiinflammatory agent and a cyclooxygenase 2 (COX-2) inhibitor; sterilizing filtration membrane; administered topically or by injection to treat nervous system disorders or injuries
03/17/2005US20050058661 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus Borrelia
03/17/2005US20050056390 Gelled starch compositions and methods of making gelled starch compositions
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 295